An IL-2 paradox: blocking CD25 on T cells induces IL-2-driven activation of CD56(bright) NK cells
Daclizumab (Dac), an Ab against the IL-2R alpha-chain, inhibits brain inflammation in patients with multiple sclerosis, while expanding CD56(bright) immunoregulatory NK cells in vivo. We hypothesized that this unexpected expansion is paradoxically IL-2 driven; caused by the increased availability of...
Saved in:
Published in | The Journal of immunology (1950) Vol. 185; no. 2; p. 1311 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
United States
15.07.2010
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!